Ospedale di Spoleto
- Research works
- 107 ▼ 51% vs 2013–17
- Citations
- 2k 18.6 per fractional work
- Top-10% rate
- 17.0% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Ospedale di Spoleto is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 8.0×. Every wedge is a field page.
- Veterinary 8.0×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Immunology and Microbiology 1.6×
- Chemistry 0.9×
- Agricultural and Biological Sciences 0.8×
- Business, Management and Accounting 0.7×
- Health Professions 0.7×
- Neuroscience 0.6×
- Earth and Planetary Sciences 0.5×
- Psychology 0.5×
- Environmental Science 0.4×
- Social Sciences 0.4×
- Engineering 0.2×
- Computer Science 0.1×
Who are the top researchers at Ospedale di Spoleto?
Ranked on the composite score, Alberto Patriti lead among researchers whose main affiliation is Ospedale di Spoleto.
- 1 Alberto Patriti Italy · #841,620 worldwide 24 citations · 18 works
Which keywords describe research at Ospedale di Spoleto?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Practice Guidelines, Diagnosis, Treatment, Chemotherapy, Management, Neoadjuvant Therapy, Robotic Surgery and Laparoscopic Surgery.
- Metastatic Gastric Cancer
- Surgical Complications
- Adjuvant Therapy
- Neoadjuvant Chemotherapy
- Tumor Markers
- Rectal Cancer
- Molecular Characterization
- Tumor Microenvironment
- Cholangiocarcinoma
- Preoperative Chemoradiotherapy
- Liver Cancer
- Survival Analysis
- Hepatocellular Carcinoma
- Transgastric Surgery
- Risk Factors
- Guidelines
- Robotic Surgery
- Management
- Treatment
- Epidemiology
- Clinical Practice Guidelines
- Diagnosis
- Chemotherapy
- Neoadjuvant Therapy
- Laparoscopic Surgery
- Prognostic Factors
- Single-Incision Laparoscopy
- Surgical Management
- Radiofrequency Ablation
- Survival
- Sorafenib
- Complications
- Immunotherapy
- Adjuvant Chemotherapy
- Endoscopic Resection
- Total Mesorectal Excision
- Gastric Cancer
- Surgery
- Pancreatic Cancer
- Lymph Node Dissection
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Practice Guidelines11▲ 19×8 topics
- Epidemiology10▲ 2.2×33 topics
- Diagnosis9▲ 8.5×17 topics
- Treatment9▲ 6.3×20 topics
- Chemotherapy8▲ 10×14 topics
- Management8▲ 9.1×14 topics
- Neoadjuvant Therapy7▲ 29×5 topics
- Robotic Surgery6▲ 43×2 topics
- Laparoscopic Surgery6▲ 46×4 topics
- Guidelines5▲ 10×9 topics
- Prognostic Factors5▲ 10×8 topics
- Risk Factors5▲ 4.5×16 topics
- Single-Incision Laparoscopy5▲ 251×1 topic
- Transgastric Surgery5▲ 251×1 topic
- Surgical Management5▲ 9.7×8 topics
- Hepatocellular Carcinoma4▲ 19×3 topics
- Radiofrequency Ablation4▲ 36×2 topics
- Survival Analysis4▲ 15×4 topics
- Survival4▲ 29×2 topics
- Liver Cancer4▲ 69×1 topic
- Sorafenib4▲ 69×1 topic
- Preoperative Chemoradiotherapy4▲ 48×2 topics
- Complications4▲ 6.5×10 topics
- Cholangiocarcinoma4▲ 42×2 topics
- Immunotherapy3▲ 4.9×7 topics
- Tumor Microenvironment3▲ 8.9×3 topics
- Adjuvant Chemotherapy3▲ 41×2 topics
- Molecular Characterization3▲ 16×4 topics
- Endoscopic Resection3▲ 31×2 topics
- Rectal Cancer3▲ 78×1 topic
- Total Mesorectal Excision3▲ 78×1 topic
- Tumor Markers3▲ 41×2 topics
- Gastric Cancer3▲ 22×2 topics
- Neoadjuvant Chemotherapy3▲ 29×2 topics
- Surgery3▲ 7.8×9 topics
- Adjuvant Therapy3▲ 21×2 topics
- Pancreatic Cancer3▲ 21×1 topic
- Surgical Complications3▲ 33×1 topic
- Lymph Node Dissection2▲ 39×1 topic
- Metastatic Gastric Cancer2▲ 39×1 topic
Which research topics does Ospedale di Spoleto publish most on?
By volume in 2022–2025: Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Cardiac Valve Diseases and Treatments and Testicular diseases and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 2 Multiple Myeloma Research and Treatments Hematology 0 works
- 3 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
- 4 Testicular diseases and treatments Surgery 0 works
- 5 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 6 IgG4-Related and Inflammatory Diseases Rheumatology 0 works
- 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 8 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
- 9 Governance, Compliance, and Sustainability Strategy and Management 0 works
- 10 Academic Research in Diverse Fields Education 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ospedale di Spoleto's research output changed?
Output in 2018–2022 was 51% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.